Indicated for: epilepsy; migraine prevention
Route of administration: oral
Substance: topiramate (antiepileptic)
ATC: N03AX11 (Nervous system | Antiepileptics | Other antiepileptics)
This medicine may affect your ability to drive or use machines.
Dose adjustment may be needed in liver disease.
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Use caution if you have glaucoma or increased eye pressure.
Effective contraception is required during treatment.
Do not use this medicine during pregnancy.
Periodic laboratory tests may be required during treatment.
Seek medical help if suicidal thoughts or major behavior changes occur.
This medicine may affect fetal development.
This medicine may cause drowsiness or reduced alertness.
This medicine may cause vision disturbances.
Topiramate is an antiepileptic drug used in the treatment of epilepsy and migraines. It works through multiple mechanisms, including blocking sodium channels, enhancing GABA (gamma-aminobutyric acid) activity, and inhibiting glutamate receptors, thereby reducing neuronal excitability.
Topiramate is administered orally, usually twice daily, with the dose gradually adjusted to minimize the risk of side effects. It is indicated both as monotherapy and as adjunctive therapy in controlling seizures and preventing migraines.
Common side effects include drowsiness, dizziness, weight loss, memory disturbances, and tingling sensations in the extremities. In rare cases, severe adverse reactions such as metabolic acidosis, glaucoma, or kidney stone formation may occur. Regular monitoring of the patient's condition is essential during treatment.
Topiramate is an effective and well-tolerated therapeutic option for managing epilepsy and migraines, contributing to improved quality of life for patients.